Unknown

Dataset Information

0

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.


ABSTRACT: Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant mortality under six months of age worldwide; therefore, the prevention of RSV infection in all infants represents a significant unmet medical need. Here we report the isolation of a potent and broadly neutralizing RSV monoclonal antibody derived from a human memory B-cell. This antibody, RB1, is equipotent on RSV A and B subtypes, potently neutralizes a diverse panel of clinical isolates in vitro and demonstrates in vivo protection. It binds to a highly conserved epitope in antigenic site IV of the RSV fusion glycoprotein. RB1 is the parental antibody to MK-1654 which is currently in clinical development for the prevention of RSV infection in infants.

SUBMITTER: Tang A 

PROVIDER: S-EPMC6742648 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant mortality under six months of age worldwide; therefore, the prevention of RSV infection in all infants represents a significant unmet medical need. Here we report the isolation of a potent and broadly neutralizing RSV monoclonal antibody derived from a human memory B-cell. This antibody, RB1, is equipotent on RSV A and B subtypes, potently neutralizes a diverse panel of clinical isolates in vitro and d  ...[more]

Similar Datasets

| S-EPMC6030461 | biostudies-literature
| S-EPMC4459498 | biostudies-literature
| S-EPMC4437463 | biostudies-literature
| S-EPMC7711572 | biostudies-literature
| S-EPMC5651886 | biostudies-other
| S-EPMC4338873 | biostudies-literature
| S-EPMC3347292 | biostudies-literature
| S-EPMC3111287 | biostudies-literature
| S-EPMC6816417 | biostudies-literature
| S-EPMC5016229 | biostudies-literature